Liang Leyi, Wang Shuze, Zhang Xiyue, Yan Tao, Pan Xiyun, Gao Yuzhong, Zhang Xing, Wang Qiang, Qu Liu
Liaoning Provincial Key Laboratory of Oral Diseases, School and Hospital of Stomatology, China Medical University, Shenyang, Liaoning 110001, China.
Department of Orthopedics and Sports Medicine and Joint Surgery, The People's Hospital of China Medical University, Shenyang, Liaoning 110016, China.
Regen Biomater. 2024 Aug 10;11:rbae090. doi: 10.1093/rb/rbae090. eCollection 2024.
Human dental pulp stem cells (hDPSCs) have demonstrated greater proliferation and osteogenic differentiation potential in certain studies compared to other types of mesenchymal stem cells, making them a promising option for treating craniomaxillofacial bone defects. However, due to low extracting concentration and long amplifying cycles, their access is limited and utilization rates are low. To solve these issues, the principle of bone-forming peptide-1 (BFP1) chemotaxis was utilized for the osteogenic differentiation of hDPSCs to achieve simultaneous and synergistic osteogenesis at multiple sites. BFP1-functionalized gelatin methacryloyl hydrogel provided a 3D culture microenvironment for stem cells. The experimental results showed that the 3D composite hydrogel scaffold constructed in this study increased the cell spread area by four times compared with the conventional GelMA scaffold. Furthermore, the problems of high stem cell dosage and low rate of utilization were alleviated by orchestrating the programmed proliferation and osteogenic differentiation of hDPSCs. , high-quality repair of critical bone defects was achieved using hDPSCs extracted from a single tooth, and multiple 'bone island'-like structures were successfully observed that rapidly induced robust bone regeneration. In conclusion, this study suggests that this kind of convenient, low-cost, island-like osteogenesis strategy involving a low dose of hDPSCs has great potential for repairing craniomaxillofacial critical-sized bone defects.
在某些研究中,与其他类型的间充质干细胞相比,人牙髓干细胞(hDPSCs)表现出更强的增殖能力和成骨分化潜力,这使其成为治疗颅颌面骨缺损的一个有前景的选择。然而,由于提取浓度低和扩增周期长,它们的获取受限且利用率低。为了解决这些问题,利用骨形成肽-1(BFP1)趋化作用原理对hDPSCs进行成骨分化,以在多个部位实现同步和协同成骨。BFP1功能化的甲基丙烯酰化明胶水凝胶为干细胞提供了三维培养微环境。实验结果表明,本研究构建的三维复合水凝胶支架与传统的甲基丙烯酰化明胶(GelMA)支架相比,细胞铺展面积增加了四倍。此外,通过调控hDPSCs的程序性增殖和成骨分化,缓解了干细胞用量高和利用率低的问题。利用从单颗牙齿中提取的hDPSCs实现了关键骨缺损的高质量修复,并成功观察到多个“骨岛”样结构,这些结构迅速诱导了强劲的骨再生。总之,本研究表明,这种涉及低剂量hDPSCs的便捷、低成本、岛状成骨策略在修复颅颌面临界尺寸骨缺损方面具有巨大潜力。